PAI
CLVS

Palo Alto Investors’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,473,967
Closed -$5.32M 33
2022
Q3
$5.32M Hold
4,473,967
0.42% 23
2022
Q2
$8.05M Hold
4,473,967
0.7% 21
2022
Q1
$9.04M Buy
4,473,967
+476,141
+12% +$962K 0.7% 22
2021
Q4
$10.8M Sell
3,997,826
-486,585
-11% -$1.32M 0.69% 23
2021
Q3
$20M Hold
4,484,411
1.21% 19
2021
Q2
$26M Hold
4,484,411
1.43% 17
2021
Q1
$31.5M Buy
4,484,411
+15,000
+0.3% +$105K 1.79% 17
2020
Q4
$21.5M Hold
4,469,411
1.12% 17
2020
Q3
$26.1M Buy
4,469,411
+108,000
+2% +$630K 1.43% 16
2020
Q2
$29.4M Sell
4,361,411
-274,378
-6% -$1.85M 1.77% 16
2020
Q1
$29.5M Sell
4,635,789
-420,497
-8% -$2.67M 2.47% 15
2019
Q4
$52.7M Buy
5,056,286
+335,542
+7% +$3.5M 2.9% 15
2019
Q3
$18.6M Sell
4,720,744
-420,560
-8% -$1.65M 1.24% 20
2019
Q2
$76.5M Sell
5,141,304
-98,000
-2% -$1.46M 3.72% 13
2019
Q1
$130M Hold
5,239,304
5.43% 8
2018
Q4
$94.1M Buy
5,239,304
+18,278
+0.4% +$328K 5.01% 8
2018
Q3
$153M Buy
5,221,026
+247,019
+5% +$7.25M 6.2% 6
2018
Q2
$226M Buy
4,974,007
+1,018,347
+26% +$46.3M 9.04% 3
2018
Q1
$209M Buy
3,955,660
+552,879
+16% +$29.2M 8.93% 2
2017
Q4
$231M Buy
3,402,781
+73,200
+2% +$4.98M 9.97% 3
2017
Q3
$274M Hold
3,329,581
11.56% 2
2017
Q2
$312M Sell
3,329,581
-565,382
-15% -$52.9M 14.55% 1
2017
Q1
$248M Buy
3,894,963
+90,875
+2% +$5.79M 11.72% 2
2016
Q4
$169M Hold
3,804,088
9.64% 3
2016
Q3
$137M Hold
3,804,088
7.97% 4
2016
Q2
$52.2M Buy
3,804,088
+342,723
+10% +$4.7M 3.94% 5
2016
Q1
$66.5M Sell
3,461,365
-86,354
-2% -$1.66M 5.16% 6
2015
Q4
$124M Buy
3,547,719
+438,911
+14% +$15.4M 6.91% 5
2015
Q3
$286M Buy
3,108,808
+707,691
+29% +$65.1M 13.75% 2
2015
Q2
$211M Buy
2,401,117
+279,260
+13% +$24.5M 9.38% 4
2015
Q1
$158M Buy
2,121,857
+19,000
+0.9% +$1.41M 7.79% 5
2014
Q4
$118M Buy
2,102,857
+381,100
+22% +$21.3M 6.91% 4
2014
Q3
$78.1M Buy
1,721,757
+806,436
+88% +$36.6M 5.83% 6
2014
Q2
$37.9M Buy
915,321
+728,421
+390% +$30.2M 2.82% 11
2014
Q1
$12.9M Hold
186,900
1.07% 22
2013
Q4
$11.3M Buy
+186,900
New +$11.3M 1.05% 23